Vitex is developing products designed to improve the safety of the world's blood supply. The Company's proprietary INACTINE technology, currently in a Phase III clinical trial, is designed to inactivate a wide range of viruses, bacteria and parasites...Show all
1108 Lavaca St.
Texas, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)